Rationale for the development and the mechanism of action of endoscopic thermal vapor ablation (InterVapor) for the treatment of emphysema

Journal of Bronchology and Interventional Pulmonology

Volumn 19, Issue 3, 2012, Pages 237-245

  Kesten, Steven ^a   Anderson, Joseph C ^b   Tuck, Stephanie A ^b  

^a Uptake Medical Corp   (United States)

^b Uptake Medical Corp   (United States)

Author keywords

Bronchoscopic; Emphysema; Lung volume reduction; Thermal energy

Indexed keywords

PAPAIN;

AIRWAY; ATELECTASIS; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EMPHYSEMA; ENDOSCOPIC THERMAL VAPOR ABLATION SYSTEM; ENDOSCOPY; ENERGY; EXPERIMENTAL DOG; FEASIBILITY STUDY; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATION; LUNG FIBROSIS; LUNG FUNCTION; LUNG RESECTION; LUNG VOLUME; MINIMALLY INVASIVE PROCEDURE; NONHUMAN; PNEUMONIA; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; REVIEW; SHEEP; TOMOGRAPHY; WATER VAPOR;

ABLATION TECHNIQUES; ANIMALS; CICATRIX; DOGS; ENDOSCOPY; FEMALE; FORCED EXPIRATORY VOLUME; HOT TEMPERATURE; HUMANS; MALE; PATIENT SELECTION; PULMONARY ATELECTASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SHEEP; STEAM; TREATMENT OUTCOME;

EID: 84863698714     PISSN: 19446586     EISSN: 19488270     Source Type: Journal    
DOI: 10.1097/LBR.0b013e31826137bc     Document Type: Review

References (23)

1. Global strategy for the diagnosis, management, and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. Available at: http://goldcopd.org/. Accessed February 2, 2011.
2. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of hyperinflation. Am Rev Respir Dis. 1993;148:1351-1357. (Pubitemid 23326038)
3. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:1557-1565.
4. Brantingan OC, Mueller E. Surgical treatment of pulmonary emphysema. Am Surg. 1957;23:789-804.
5. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109:106-116.
6. The National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volumereduction surgery with medical therapy for severed emphysema. N Engl J Med. 2003;348:2059-2073.
7. Criner GJ, Cordova F, Sternberg AL, et al. The National Emphysema Therapy Trial (NETT). Part II: Lessons learned about lung volume reduction surgery. Am J Resp Crit Care Med. 2011;184:881-893.
8. Naunheim KS, Wood DE, Mohsenifar Z, et al. National Emphysema Treatment Trial Research Group. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82:431-443.
9. Berger RL, Decamp MM, Criner GJ, et al. Lung volume reduction therapies for advanced emphysema: an update. Chest. 2010;138:407-417.
10. Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363:1233-1244.
11. VENT Pivotal Trial Clinical Study Report, 2008, Emphasys Medical Inc., (2008). Available at http://www.fda.gov/. Accessed February 2, 2011.
12. Sterman DH, Mehta AC, Wood DE, et al. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration. 2010;79:222-233.
13. Cardoso PF, Snell GI, Hopkins P, et al. Clinical application of airway bypass with paclitaxel-eluting stents: early results. J Thorac Cardiovasc Surg. 2007;134:974-981. (Pubitemid 47454624)
14. Shah PL, Slebos DJ, Cetti E, et al. Bronchoscopic lungvolume reduction with exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicenter trial. Lancet. 2011;378:997-1005.
15. Herth FJ, Gompelmann D, Stanzel F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal (R)). Respiration. 2011;82:36-45.
16. Herth FJ, Eberhard R, Gompelmann D, et al. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis. 2010;4:225-231.
17. Emery MJ, Eveland RL, Eveland K, et al. Lung volume reduction by bronchoscopic administration of steam. Am J Resp Crit Care Med. 2010;182:1282-1291.
18. Tuck SA, Lopes-Berkas V, Beam S, et al. Bronchoscopic thermal vapor ablation in a canine model of emphysema. Int J COPD. 2012;7:21-31.
19. Snell GI, Hopkins P, Westall G, et al. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg. 2009;88:1993-1998.
20. Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapor ablation therapy in the management of heterogeneous emphysema. Eur Resp J. 2012;83:400-406.
21. Herth FJF, Ernst A, Baker KM, et al. Characterization of outcomes one year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J COPD. 2012. Accepted for publication.
22. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178:332-338.
23. Tashkin DP, Celli B, Senn S, et al. UPLIFT investigators. A four year trial of tiotropium in patients with chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543-1554.